Neuroleptic-induced tardive dyskinesia improved after treatment of thyrotoxicosis. Neuroleptic blood levels indicated that the improvement was not caused by masking of the symptoms by rising drug levels. Dopamine metabolite measurements suggested that the thyrotoxicosis caused an increase in the sensitivity of caudate neurons to dopamine, rather than a change in release of dopamine.
References
1.
HamadahK., TegginA.F.Haloperidol, thyrotoxicosis and neurotoxicity.Lancet1974; 2: 1019–20.
2.
WeinerM.F.Haloperidol, hyperthyroidism and sudden death.Am J Psychiatry1979; 136: 717–8.
3.
YosselsonS., KaplanA.Neurotoxin reaction to haloperidol in a thyrotoxic patient.N Engl J Med1975; 293: 301.
4.
FidlerS.M., O'RourkeR.A., BuschsbaumH.W.Choreoathetosis as a manifestation of thyrotoxicosis.Neurology1971; 21: 55–7.
5.
HeffronW.S., EatonR.P.Thyrotoxicosis presenting as choreoathetosis.Ann Intern Med1976; 73: 425–8.
6.
KlawansH., ShenkerS.Observations on the dopaminergic nature of hyperthyroid chorea.J Neurol Transm1972; 33: 73–81.
7.
SattlerH.Basedow's disease. (Translation by GW and JF Marchand).New York: Grune and Stratton, 1972.
8.
SmithR.C., TammingaC.A., HarasztiJ.. Effects of dopamine agonists in tardive dyskinesia.Am J Psychiatry1977; 134: 763–8.
9.
MurphyR.C., HattoxS.E., HeibigH.R.Application and evaluation of limited mass recording with a gas chromatograph-mass spectrometer-computer system.Biomed Mass Spectrom1978; 5: 444–8.
WhybrowP.C., PrangeA.A hypothesis of thyroid-catecholamine-receptor interaction.Arch Gen Psychiatry1981; 38: 106–13.
12.
RastogiR.B., LapierreY.D., SinghaiR.L.Diazepam modifies L-triiodothyronine-stimulated changes in behaviour and the metabolism of brain norepinephrine, dopamine and 5-hydroxytryptamine — a possible mechanism of action.J Psychiatr Res1979; 15: 7–20.
13.
KopinI.Measuring turnover of neurotransmitters in human brain. In: LiptonM.A., DiMascioA., KillamK.F., eds. Psychopharmacology: a generation of progress.New York: Raven Press, 1978: 933–42.
14.
CrowleyT.J., HoehnM.M., RutledgeC.O.. Dopamine excretion and vulnerability to drug-induced parkinsonism.Arch Gen Psychiatry1978; 35: 97–104.
15.
ChaseT.N.Catecholamine metabolism and neurologic disease.Biochem Pharmacol1974; 23(Suppl): 941–6.
16.
GranacherR.P.Differential diagnosis of tardive dyskinesia: an overview.Am J Psychiatry1981; 138: 1288–97.
